BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• DH Recalls Eumed Biotechnology Co. Ltd.'s EUKARE Blood Glucose Test Strip

  March 5, 2012

   · 

  1 min read
• Cellmid Limited (ASX: CDY) Release: Annual Report on Celera (Quest) License

  March 5, 2012

   · 

  4 min read
• Policy

  Australia’s Therapeutic Goods Administration is Lax on Device Safety

  March 5, 2012

   · 

  1 min read
• Drug Development

  Madrigal Pharmaceuticals Launches Multiple Dose Phase I Clinical Study for 3196 in Dyslipidemia

  March 5, 2012

   · 

  3 min read
• Loewen, Ondaatje, McCutcheon Initiates Independent Analyst Coverage on Cynapsus Therapeutics

  March 5, 2012

   · 

  4 min read
• Drug Development

  Thrombotech Ltd. Receives Regulatory Approval for Phase IIa Trials in the U.S.

  March 5, 2012

   · 

  3 min read
• Business

  Milestone Pharmaceuticals Appoints Paul Truex to the Board of Directors

  March 5, 2012

   · 

  1 min read
• Euromedic International Streamlines Purchasing With IVALUA Buyer

  March 5, 2012

   · 

  4 min read
• Eli Lilly and Company and Its Big Bet on Alzheimer’s Drug

  March 5, 2012

   · 

  1 min read
• Drug Development

  Meda AB: Positive Results for Dymista in Three Clinical Studies

  March 5, 2012

   · 

  9 min read